NEW YORK (Reuters Health) – The diagnosis of colorectal cancer will be delayed or missed in a substantial number of patients with inflammatory bowel disease (IBD) if colonoscopic surveillance is conducted strictly according to official guidelines, investigators in the Netherlands report.
Guidelines of the American Gastroenterological Association and the British Society for Gastroenterology recommend that cancer surveillance be started 8-10 years after a diagnosis of Crohn












